Global Hospital Infection Therapeutics Market Trends, Growth and Forecasts 2015-2019: Hexa Reports

Hexa Reports

Market Research Reports and Insightful Company Profiles

Global Hospital Infection Therapeutics Market Share, Size,

Trends, Growth, Analysis, Outlook, Segmented Overview

and Forecasts 2015-2019

Hospital-acquired diseases are also known as nosocomial infections that are acquired in hospitals and

other healthcare facilities. These infections are classified only when a patient is admitted for reasons

other than the infections and are caused by bacteria, fungi, parasites, or viruses.

Most common types of hospital-acquired infections are SSIs, UTIs, bloodstream infections,

pneumococcal infections, MRSA, and gastrointestinal illnesses. These infections appear between 48

hours and four days after a patient is admitted and are usually related to a treatment of procedure used

to treat or diagnose the patient's initial illness or injury.

Browse Detail Report With TOC @

http://www.hexareports.com/report/global-hospital-infection-therapeutics-market/details

Hospital-acquired diseases are preventable through adherence to strict guidelines and less usage of

invasive equipment that must be followed by healthcare professionals while caring for the patient. Antiinfective drugs are used for the treatment of these infections. These infections can be minimized by

following proper infection control measures in the hospitals and healthcare institutions.

Technavio's analysts forecast the global hospital infection therapeutics market to grow at a CAGR of

3.24% over the period 2014-2019.

Hexa Reports

Market Research Reports and Insightful Company Profiles

Covered in this report

The report covers the present scenario and growth prospects of the global hospital infection

therapeutics market for the period 2015-2019. To calculate the market size, the report considers

revenue generated from the sales of drugs used in the treatment of various hospital-acquired infections

such as bloodstream infections, Clostridium difficile infections, hospital-acquired pneumonia, surgical

site...